Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:KNE)

Kane Biotech Announces First Quarter 2024 Financial Results

GlobeNewswire 9 days ago

Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024

GlobeNewswire May 16, 2024

Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map

GlobeNewswire May 15, 2024

Kane Biotech to Host Investor Webinar

GlobeNewswire April 16, 2024

Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products

GlobeNewswire April 15, 2024

Kane Biotech to sell its STEM Animal Health for C$11.5 million

Jocelyn Aspa April 11, 2024

Canadian Investment Regulatory Organization Trade Resumption - KNE

Canada NewsWire April 11, 2024

Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health

GlobeNewswire April 11, 2024

Canadian Investment Regulatory Organization Trading Halt - KNE

Canada NewsWire April 11, 2024
View More News ››

Opinion & Analysis (TSXV:KNE)

Emerging opportunity in a growing, high-value dermatological market

Ryan Dhillon April 11, 2024

Big Copper Fox Metals’ (V.CUU) shareholders under water?

Stockhouse Editorial September 17, 2014

John Kaiser: ‘The bull is back,’ Stockhouse poster says

Stockhouse Editorial February 5, 2014
View More Opinion ››

Bullboard Posts (TSXV:KNE)

RE:New Press Release - Kane Biotech Announces First Quarter 2024 Financial Results

Interesting to see that STEM Animal sales was picking up in Q1...that explain why they got a good offer from Dechra. The AGM meeting was...
francoisl13 - 8 days ago

Technically speaking (update)

As mentioned before, technical analysis for a microcap company is not as good as for larger companies but, it is interesting to note the...
francoisl13 - May 17, 2024

Latest from Progenacare LinkedIN

New Revyve data provided by Progenacare at the SAWC in Orlando. Here's an excerpt of their LinkedIN post; ''Poster Preview...
francoisl13 - May 15, 2024

SAWC (Orlando,FL) May 2024

Interesting piece of info found on the Progenacare LinkedIN page; ''We will also be presenting new clinical and scientific data...
francoisl13 - May 13, 2024

Convatec - 2023 annual report

For those interesting by the wound care market (you should if you are following or have invested in KNE), please take 10-15 minutes ot...
francoisl13 - May 3, 2024

RE:LinkedIN - Have a look....

LinkedIN - take 2 Please have another look at KaneBiotech LinkedIN page. Pay attention to the latest post, It is interesting to note...
francoisl13 - May 3, 2024
View more Bullboard ››

Indiva Ltd

Indiva Ltd

Indiva Limited, through its indirect wholly owned subsidiary, Indiva Inc., is a Canada-based producer of cannabis servicing ...
View More »